Product Information
STELARA 90 MG/ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $29792.7867 per ML under NDC 57894006103. Its NADAC has been published 661 times since Nov 28, 2013.
Strength
90 mg/mL
Manufacturer
Janssen Biotech, Inc.NDC
57894006103
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
USTEKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125261On Market Since
9/25/2009
Pharmacological Classes
Price Statistics
The NADAC for STELARA 90 MG/ML SYRINGE has been published 661 times since Nov 28, 2013, and over the history we have for it it has risen 130.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29792.7867 per ML |
|---|---|
| All-time high | $29843.8000 (Aug 12, 2026) |
| All-time low | $12951.1987 (Nov 28, 2013) |
| 52-week high | $29843.8000 |
| 52-week low | $28364.3697 |
| Median price | $22344.1917 |
| Average price | $21805.3103 |
| Largest weekly change | +10.4% (Aug 19, 2015) |
| Weeks tracked | 661 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ustekinumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Biotech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ustekinumab market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Interleukin-23 Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of STELARA 90 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for STELARA 90 MG/ML SYRINGE, manufactured by Janssen Biotech, Inc., is $29792.7867 per ML (NDC 57894006103), effective Sep 30, 2026.
How has the price of STELARA 90 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for STELARA 90 MG/ML SYRINGE has risen 130.0%. It has been tracked across 661 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for STELARA 90 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for STELARA 90 MG/ML SYRINGE has ranged from a low of $12951.1987 (Nov 28, 2013) to a high of $29843.8000 (Aug 12, 2026), with a median of $22344.1917 per ML.
Are there cheaper alternatives to STELARA 90 MG/ML SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of STELARA 90 MG/ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures STELARA 90 MG/ML SYRINGE?
STELARA 90 MG/ML SYRINGE (NDC 57894006103) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.